[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593125":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":57,"collaborators":18,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":18,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":18,"overallStatus":41,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Procedural video viewing Group","EXPERIMENTAL","Participants will watch an educational video explaining the injection procedure prior to treatment.",[13],"Behavioral: Procedure video viewing",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Participants will not view the video before the treatment.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Procedure video viewing","Patients who have never had an intravitreal injection before will be randomly assigned to watch an educational video about the procedure prior to treatment.",[9],[26],{"name":27,"affiliation":5,"role":28},"Xiaoyun Fang, MD., PhD","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Xiaoyun Fang, MD., PhD.","CONTACT","+ 86 13588411946","xiaoyunfang@zju.edu.cn",{"name":36,"role":32,"phone":37,"phoneExt":18,"email":38},"Fang Zheng, MD., PhD","+86 18258499106","zhengfanggo@zju.edu.cn",[40],{"facility":5,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Hangzhou","Zhejiang","310009","China","CN",{"type":48,"coordinates":49},"Point",[50,51],120.16142,30.29365,{"lat":51,"lon":50},[54],{"name":55,"role":32,"phone":56,"phoneExt":18,"email":38},"Fang Zheng","18258499106",{"type":58,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100593125","effect-of-video-viewing-on-intravitreal-injection-experience-100593125",false,"NCT07002372","Effect of Video Viewing on Intravitreal Injection Experience","Impact of Procedural Video Viewing on Patients Undergoing Intravitreal Anti-VEGF Injections","Inclusion Criteria:\n\n* Patients who are receiving their first intravitreal injection of anti-VEGF medication due to retinal diseases\n* Mentally competent, and able to communicate without barriers\n* Willing to voluntarily sign an informed consent form.\n\nExclusion Criteria:\n\n* History of previous eye surgery\n* Best-corrected visual acuity in the better eye worse than 0.3\n* The target eye is complicated with neovascular glaucoma.","ALL","18 Years",{"count":69,"type":70},182,"ESTIMATED","INTERVENTIONAL",[73],"NA","Study Objective The goal of this clinical trial is to evaluate whether viewing a procedural video can improve the patient experience and reduce the incidence and severity of subconjunctival hemorrhage in individuals undergoing intravitreal anti-VEGF injections.\n\nKey Research Questions\n\n1. Can viewing the procedural video prior to treatment reduce the rate and\u002For area of subconjunctival hemorrhage?\n2. Can the video improve the patient experience, specifically by reducing anxiety levels and increasing satisfaction with the treatment process?\n\nStudy Design Participants will be randomly assigned to either an intervention group, who will watch an educational video explaining the injection procedure, or a control group, who will not view the video.\n\nAll participants will complete the State-Trait Anxiety Inventory-State (STAI-S) questionnaire both before and after treatment to assess changes in anxiety levels.",[76,77,78,79,80],"Age Related Macular Degeneration","Diabetic Retinopathy","Choroidal Neovascularization","Retinal Vein Occlusion","Cystoid Macular Edema","2025-06-01",{"date":83,"type":84},"2025-06-03","ACTUAL",{"date":86,"type":84},"2025-05-05",{"date":88,"type":70},"2025-10-05",{"name":5,"class":6},1]